Urticaria pp 161-181 | Cite as

Urticaria Therapy

  • B. M. Henz
  • T. Zuberbier
  • E. Monroe


In contrast to the complex diagnostic approaches and procedures in urticaria, the therapy of most types of this disease is simple and logical (Fig. 11.1).


Allergy Clin Immunol Chronic Urticaria Sorbic Acid Chronic Idiopathic Urticaria Urticarial Vasculitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Belaich S, Bruttman G, DeGreef H, Lachapelle TM, Paul E, Pedrali P, Tennstedt O (1990) Comparative effects of laratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 64:191 –194PubMedGoogle Scholar
  2. Borish L, Tamir R, Rosenwasser LJ (1987) Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 80: 314–319PubMedCrossRefGoogle Scholar
  3. Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P (1996) Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 51: 320–325PubMedGoogle Scholar
  4. Cerio R, Lessof MH (1984) Treatment of chronic idiopathic urticaria with terfenadine. Clin Allergy 14: 139–141PubMedCrossRefGoogle Scholar
  5. Cook LJ, Shuster S (1983) Lack of effect of cimetidine in chronic idiopathic urticaria. Acta Dermatol Venereol 63: 265–267Google Scholar
  6. Czarnetzki BM, Behrend H (1981) Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Brit J Dermatol 105: 563–567CrossRefGoogle Scholar
  7. Czarnetzki BM (1986) Urticaria. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  8. Czarnetzki BM, Algermissen B, Jeep S, Haas N, Niirnberg W, Miiller K, Kropp J-D (1994) Interferone treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 30: 500–501PubMedCrossRefGoogle Scholar
  9. Czarnetzki BM (1991) Chronic urticaria. In: Lichtenstein LM, Fauci AS (ed) Current therapy in allergy, immunology and rheumatology. 4th edn. Decker, Toronto, pp 49–52Google Scholar
  10. Czarnetzki BM (1994) Neues zur Diagnostik und Therapie der Urtikaria. Allergologie 17: 2–5Google Scholar
  11. DeVries JE (1994) Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J Invest Dermatol 102: 141–144CrossRefGoogle Scholar
  12. Ferguson J, MacDonald KJS, Kenicer KJA (1985) Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomized double-blind study. Br J Clin Pharmacol 20: 639–641PubMedGoogle Scholar
  13. Fradin MS, Ellis CN, Goldfarb MT, Voorhees JJ (1991) Oral cyclosporin for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 25: 1065–1067PubMedCrossRefGoogle Scholar
  14. Fredriksson T, Herslek T, Hjorth N (1986) Terfenadine in chronic urticaria: a comparison with clemastine and placebo. Cutis 38: 128–130PubMedGoogle Scholar
  15. Gibson A, Clancy R (1980) Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy 10: 699–704PubMedCrossRefGoogle Scholar
  16. Golden DBK, Kwiterovich KA,Kagey-Sobotka A, Valentine MD, Lichtenstein LM (1996) Discontinuing venom immunotherapy: Outcome after five years. J Allergy Clin Immunol 97: 579–587PubMedCrossRefGoogle Scholar
  17. Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS, Drayton G, Indianer L, Peter JB, Barr RJ (1986) Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 78: 867–873PubMedCrossRefGoogle Scholar
  18. Grabbe J, Czarnetzki BM (1992) Akute und chronische Urtikaria. Dt. Med. Wochenschr 117: 1365–1370CrossRefGoogle Scholar
  19. Grant JA, Bernstein DI, Buckley CE, Chu T, Fox R, Rocklin R, Schoenwetter W, Spector S, Stafford C, Stroh T, Karpenter K (1988) Double–blind comparison of terfenadine, chlor–pheniramine and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 81: 574–579PubMedCrossRefGoogle Scholar
  20. Greaves M, Marks R, Robertson I (1977) Receptors for histamine in human skin blood vessels: a review. Br J Dermatol 97: 262–266CrossRefGoogle Scholar
  21. Greene SL, Reed CE, Schroeter AL (1985) Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 12: 669–675PubMedCrossRefGoogle Scholar
  22. Greineder DK (1996) Risk management in allergen immunotherapy. J Allergy Clin Immunol 98: 330–334Google Scholar
  23. Harto A, Sentagorda E, Ledo A (1985) Doxepin in the treatment of chronic urticaria. Dermatologica 170: 90–95PubMedCrossRefGoogle Scholar
  24. Harvey RP, Wegs J, Schocket AL (1981) A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 68: 262–266PubMedCrossRefGoogle Scholar
  25. Hashiro M, Yamatodani Y (1996) A combination therapy of psychotropic drugs and antihistaminics or antiallergics in patients with chronic urticaria. J Dermatol Sci 11: 209–213PubMedCrossRefGoogle Scholar
  26. Haustein U (1996) Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm Venereol (Stockh) 76: 498–499Google Scholar
  27. Helfman T, Falanga V (1995) Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 32: 254–258CrossRefGoogle Scholar
  28. Henz BM, Zuberbier T, O’Keefe E, Metzenauer P (1997) Differential effects of new generation H1-receptor antagonists in pruritic dermatoses. Allergy, submittedGoogle Scholar
  29. Juhlin L (1981) Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 104: 369–381PubMedCrossRefGoogle Scholar
  30. Juhlin L, Arendt C (1988) Treatment of chronic urticaria with cetirizine dihydrochloride, a non-sedating antihistamine. Br J Dermatol 119: 67–72PubMedCrossRefGoogle Scholar
  31. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M (1990) Urticaria: clinicl efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86: 1014–1018PubMedCrossRefGoogle Scholar
  32. Kaur S, Greaves M, Eftekhari N (1981) Factitious urticaria (dermographism): treatment of cimetidine and chlorpheniramine in a randomized double blind study. Br J Dermatol 104: 185–190PubMedCrossRefGoogle Scholar
  33. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW (1991) Clinical and immune-logical follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 88: 339–348PubMedCrossRefGoogle Scholar
  34. Kenneth CD, Ellis CN (1991) Pharmacologic therapy for urticaria. J Am Acad Dermatol 25: 176–189CrossRefGoogle Scholar
  35. Kemp JP (1992) Antihistamines — is there anything safe to prescribe? Ann Allergy 69: 276–280PubMedGoogle Scholar
  36. Krause L, Shuster S (1983) Mode of action of HI antihistamines in itch. Br J Dermatol 109 (Suppl 24): 30CrossRefGoogle Scholar
  37. Lippert U, Krüger-Krasagakes S, Möller A, Kiessling U, Czarnetzki BM (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the HI-antagonist descarboethoxyloratadine and dexamethasone from human mast and basophilic cell lines. Exp Dermatol 4: 272–276PubMedCrossRefGoogle Scholar
  38. Mansfield LE, Smith JA, Nelson HS (1983) Greater inhibition of dermographia with combination of H1 and H2 antagonists. Ann Allergy 50: 264–265PubMedGoogle Scholar
  39. Matthews CNA, Boss JM, Warin RP, Storari F (1979) The effect of HI and H2 histamine antagonists on symptomatic dermographism. Br J Dermatol 101: 57–61PubMedCrossRefGoogle Scholar
  40. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CT (1981) Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 117: 404–407PubMedCrossRefGoogle Scholar
  41. Monroe EW (1988) Chronic urticaria: review of non-sedating H1 antihistamines in treatment. J Am Acad Dermatol 19:842–849Google Scholar
  42. Monroe EW, Fox R, Kalivas J, Katz I, Bernstein D, Honsinger R, Grabier S, Garvin P, Cuss F, Lutsky B (1991) Comparative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. J Allergy Clin Immunol 87: 224CrossRefGoogle Scholar
  43. Monroe EW, Bernstein D, Bronsky E, Hanifin J, Prenner B, Schoenwetter W, Spector S, Stafford C, Stroh J, Wanderer A (1992) A doubleblind, randomized, placebo controlled, parallel study comparing the safety and efficacy of ternenadine 60 mg bid to hydroxyzine 25 mg qid administered for 6 to 12 weeks in the treatment of chronic idiopathic urticaria [Abstract]. Clin Res Rep 43: 1Google Scholar
  44. Neittaanmäki H, Hyöhänen T, Fräki JE (1984) Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: Usefulness of doxepin. J Am Acad Dermatol 11: 483–489PubMedCrossRefGoogle Scholar
  45. Nürnberg W, Grabbe J, Czarnetzki BM (1994) Synergistic effects of combined pentoxifylline and dapsone in leukocytoclastic vasculitis. Lancet 343: 49CrossRefGoogle Scholar
  46. Paul E, Bodeker RH (1986) Treatment of chronic urticaria with terfenadine and ranitidine: a randomized doubleblind study in 45 patients. Eur J Clin Pharm 31: 277–280CrossRefGoogle Scholar
  47. Richelson E (1979) Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc 54: 669–674PubMedGoogle Scholar
  48. Rudzki E, Czubalski K, Grzywa Z (1980) Detection of urticaria with food additives intolerance by means of diet. Dermatologica 161: 57–62PubMedCrossRefGoogle Scholar
  49. Simons FR, McMiilan JL, Simons KJ (1990) A double-blind, single-dose crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo, suppression effects on histamine-induced wheals and flared during 24 hours in normal subjects. A Allergy Clin Immunol 86: 540–547CrossRefGoogle Scholar
  50. Simons FER (1992) The antiallergic effects of antihistamines (H1-receptor antagonists). J Allergy Clin Immunol 90: 705–715PubMedCrossRefGoogle Scholar
  51. Soter NA, Austen KF, Wasserman SI (1979) Oral sodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301: 465–469PubMedCrossRefGoogle Scholar
  52. Spector SL, Altman R (1987) Cetirizine, a novel antihistamine. Am J Rhinol 1: 147–149CrossRefGoogle Scholar
  53. Sullivan T (1982) Pharmacologic modulation of the whealing response to histamine in human skin: identification of doxepin as a potent in vivo inhibitor. J Allergy Clin Immunol 69: 260–267PubMedCrossRefGoogle Scholar
  54. Tharp MD (1996) Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol 98: S 325–S 330CrossRefGoogle Scholar
  55. Yee KC, Cunliffe WJ (1994) Progesterone-induced urticarial- response to buserelin. Br J Dermatol 130: 121–123PubMedCrossRefGoogle Scholar
  56. Zuberbier T, Aberer W, Burtin M, Rihoux J-P, Czarnetzki BM (1995a) Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol (Stockh) 75:147–149Google Scholar
  57. Zuberbier T, Chantraine-Heß S, Czarnetzki BM (1995b) The role of food intolerance in chronic urticaria — a prospective study. Acta Derm Venereol (Stockh) 75: 484–487Google Scholar
  58. Zuberbier T, Iffländer J, Semmler C, Czarnetzki BM (1996) Acute urticaria — clinical aspects and therapeutic responsiveness. Acta Derm Venereol (Stockh) 76: 295–297Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • B. M. Henz
  • T. Zuberbier
  • E. Monroe

There are no affiliations available

Personalised recommendations